NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Care Facilities · USD

DaVita Inc. (DVA) Stock Analysis

DaVita Inc. (DVA) is a Medical Care Facilities stock listed on NYSE and quoted in US Dollar.

DVA

$183.99

+$2.33 (+1.28%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare DVA with… →

DVA Key Statistics

As of Sep 4, 2026
Trading
Open
$180.97
Previous Close
$181.66
Day's Range
179.95–184.13
52-Week Range
101.00–247.49
Volume
473.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.83
Valuation
Market Cap
$11.74B
P/E Ratio
15.38
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
10.67
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.44
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.84
EPS (ttm)Profit attributable to each share over the last twelve months.
11.96
Financials (FY)
Revenue (FY)
$13.64B+6.46%
Net Income (FY)
$746.80M−20.24%
Profit marginThe share of revenue left as profit after all costs and taxes.
6.05%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
63.80M
1-Year Return
+35.73%
Dividend and dates
Earnings Date
October 28, 2026estimated
Avg Volume
834.32K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

DVA Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+61.95%
2025−24.03%
2024+42.75%
2023+40.30%
2022−34.36%
2021−3.10%
2020+56.47%
2019+45.80%
2018−28.78%
2017+12.54%
2016 (partial year)−14.81%

As of September 4, 2026.

DVA Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$13.64B$746.80M5.5%
2024$12.82B$936.34M7.3%
2023$12.14B$691.54M5.7%
2022$11.61B$560.40M4.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$13.64B$4.40B$2.01B$746.80M5.5%
2024$12.82B$4.22B$1.95B$936.34M7.3%
2023$12.14B$3.82B$1.60B$691.54M5.7%
2022$11.61B$3.40B$1.31B$560.40M4.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

DVA Valuation vs Medical Care Facilities Median

Median of 57 stocks
MetricDVAMedical Care Facilities medianvs median
P/E15.3819.8422% below
P/S ratio0.840.9512% below
Profit margin6.05%3.06%3.0 pts above

Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

DaVita Inc. (DVA) is capitalised at $11.74B on the latest close. The company sits in the Healthcare sector, in the Medical Care Facilities industry. Headcount on file is 78,000.

DVA last closed at $183.99 on September 4, 2026. That is +$2.33 (+1.28%) against the previous close. The 52-week range on file runs from $101.00 to $247.49. The latest close sits 82.17% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $13.64B. That is +6.46% against the prior fiscal year, when revenue was $12.82B. The same year closed with net income of $746.80M. That is −20.24% against the prior fiscal year. The reported profit margin is 6.05%. That is 3 percentage points above the Medical Care Facilities median of 3.06%. Earnings per share on a trailing basis come to 11.96.

Across the 4 fiscal years on file, revenue moves from $11.61B in 2022 to $13.64B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

DVA trades at a trailing price-to-earnings ratio of 15.38. That is 22.48% below the Medical Care Facilities median of 19.84. The forward P/E on file is 10.67. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.44. Measured against sales, the shares trade at 0.84 times revenue. On price-to-sales that is 11.84% below the Medical Care Facilities median of 0.95. The medians here are taken across 57 Medical Care Facilities companies that report the metric.

The trailing one-year price return is +35.73%. Across 10 years the annualized return works out at +11.00%. The reported beta is 0.83. Daily returns over the trailing 10 years annualize to a volatility of 35.2%.

Growth & Income

The record shows no dividend for DVA.

The strongest complete calendar year on file is 2020 at +56.47%; the weakest is 2022 at −34.36%. Of the 9 complete calendar years on file, 5 finished higher. 2026 is still running; the price is +61.95% year to date.

Peer Comparison

DaVita Inc. (DVA) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
DaVita Inc. DVA $11.74B 15.4
HCA Healthcare, Inc. HCA $87.68B 13.6
Tenet Healthcare Corporation THC $21.34B 10.2
Fresenius Medical Care AG FMS $12.06B 11.7

The Medical Care Facilities industry average P/E ratio is 19.8x. DaVita Inc. trades at a P/E of 15.4.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Care Facilities Stocks

HCA

HCA Healthcare, Inc.

$87.68B

 THC

Tenet Healthcare Corporation

$21.34B

 FMS

Fresenius Medical Care AG

$12.06B

 EHC

Encompass Health Corporation

$12.01B

 UHS

Universal Health Services, Inc.

$10.00B

 ENSG

The Ensign Group, Inc.

$9.95B
View all Medical Care Facilities stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Visit website →